M Bayes, X Rabasseda, JR Prous - Methods and findings in experimental and clinical …, 2006 - journals.prous.com Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP
Mohana Priya, M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G.
Krithiga and E. Banu Rekha. Cited by 148 - Related articles - All 9 versions
- ►tripod.com [PDF] E Canalis, A Giustina, JP Bilezikian - The New England Journal of Medicine, 2007 - nejm.highwire.org Osteoporosis, a major worldwide health problem, affects 4 million to 6 million
women and 1 million to 2 million men in the United States. Even more people have
decreased bone mass, which, in addition to other risk factors, can be a ... Cited by 68 - Related articles - BL Direct - All 8 versions
- ►reumagalicia.com [PDF] P Szulc, PD Delmas - Osteoporosis International, 2008 - Springer Abstract Introduction The aim was to analyse data on the use of biochemical bone
turnover markers (BTM) in postmeno- pausal osteoporosis. Methods We carried out
a comparative analysis of the most important papers concerning BTM in ... Cited by 17 - Related articles - All 3 versions
- ►iscd.org [PDF] K Engelke, JE Adams, G Armbrecht, P Augat, … - Journal of Clinical Densitometry, 2008 - Elsevier The International Society for Clinical Densitometry (ISCD) has developed
Official Positions for the clinical use of dual-energy X-ray absorptiometry
(DXA) and non-DXA technologies. While only DXA can be used for diagnostic ... Cited by 14 - Related articles - All 34 versions
A Grey - Expert Opin. Emerging Drugs, 2007 - informahealthcare.com Osteoporotic fractures are an important public health problem, contributing
substantially to morbidity and mortality in an ageing world population and
consuming considerable health resources. Presently available pharmacologic ... Cited by 8 - Related articles - BL Direct - All 6 versions
T Sugiyama, LK Saxon, G Zaman, A Moustafa, … - Bone, 2008 - Elsevier The separate and combined effects of intermittent parathyroid hormone (iPTH)
(1–34) and mechanical loading were assessed at trabecular and cortical sites
of mouse long bones. Female C57BL/6 mice from 13 to 19 weeks of age were ... Cited by 7 - Related articles - All 23 versions
- ►uhasselt.be [PDF] PP Geusens, CH Roux, DM Reid, WF Lems, S … - Nature Clinical Practice Rheumatology, 2008 - medscape.com Many randomized controlled trials (RCTs) have investigated drug treatment for
women at high risk of fracture, with a reduction in fracture risk as their end
point. There has also been progress in identifying women at the highest ... Cited by 5 - Related articles - BL Direct - All 8 versions
- ►snmjournals.org AEB Moore, GM Blake, I Fogelman - Journal of Nuclear Medicine, 2008 - Soc Nuclear Med Quantitative studies of bone using 99m Tc-methylene diphosphonate ( 99m Tc-MDP)
have a potentially valuable role in investigating the treatment of patients with
metabolic bone disease. In this study we compared 3 different methods of ... Cited by 6 - Related articles - BL Direct - All 3 versions
P Valverde - Current medicinal chemistry, 2008 - ingentaconnect.com Tufts University School of Dental Medicine, Department of General Dentistry,
Boston, MA 02111, USA Abstract: In this review, benefits and side-effects of
current and emerging therapies to treat and prevent pathological bone loss ... Cited by 5 - Related articles - BL Direct - All 5 versions
D Goltzman - Archives of biochemistry and biophysics, 2008 - Elsevier Parathyroid hormone (PTH) has been viewed as catabolic for bone. Nevertheless,
exogenous PTH is anabolic when administered intermittently, at a frequency that
permits complete clearance between doses. In the fetus and neonate, ... Cited by 5 - Related articles - All 4 versions
